Female fertility and the zona pellucida

  1. Paul M Wassarman  Is a corresponding author
  2. Eveline S Litscher
  1. Department Cell, Developmental, and Regenerative Biology Icahn School of Medicine at Mount Sinai One Gustave L. Levy Place, United States

Abstract

Fertility in female mammals, including mice and humans, is dependent on the presence of a zona pellucida (ZP) around growing oocytes and unfertilized eggs. A ZP is required to stabilize contacts between oocyte microvilli and follicle cell projections that traverse the ZP to form gap junctions that support the health of growing oocytes and developing follicles. In the absence of a ZP, due to inactivation or mutation of genes encoding ZP proteins, there is a loss of contacts between growing oocytes and neighboring follicle cells and a concomitant reduction in the production of ovulated eggs that results in female infertility.

Introduction to the mammalian zona pellucida

The zona pellucida (ZP) is a relatively thick extracellular matrix (ECM) that surrounds all mammalian oocytes, eggs, and preimplantation embryos, from monotremes that lay eggs to placental mammals (Wassarman and Litscher, 2016; Wassarman and Litscher, 2021). During oogenesis, small nongrowing oocytes that lack a ZP undergo tremendous growth to give rise to fully grown oocytes that have a ZP (Figure 1). Fully grown oocytes become unfertilized eggs when released or ovulated from the ovary into the fallopian tube where they may be fertilized by sperm. As oocytes begin to grow in the ovary the ZP first appears as diffuse fibrils in localized pockets around the surface of growing oocytes and shortly thereafter the fibrils coalesce to form a uniform ZP that continues to thicken as oocytes grow. Messenger RNA (mRNA) encoding ZP proteins is undetectable in nongrowing oocytes, but as soon as oocytes begin to grow ZP mRNA can be detected and increases to hundreds-of-thousands of copies in fully grown oocytes. A ZP consists of long interconnected fibrils laid down by a growing oocyte during oogenesis as ovarian follicles mature and prepare to ovulate an unfertilized egg.

Photographic image of a light micrograph (Nomarski differential interference contrast) of an unfertilized mouse egg incubated in the presence of free-swimming sperm.

Sperm are shown bound to the zona pellucida. Scale bar (≃1 cm) = ≃14 µm.

During fertilization, free-swimming sperm recognize and bind to the ZP of unfertilized eggs (Figure 1) in a species-restricted manner, penetrate through the ZP, and fuse with egg plasma membrane to form a zygote. Shortly after an egg is fertilized, the ZP undergoes changes that affect its physical and biological properties that are important for preventing polyspermy and protecting preimplantation embryos in the female reproductive tract. For example, free-swimming sperm are unable to bind to the ZP of fertilized eggs or cleavage-stage embryos. The ZP of oocytes and eggs is a viscoelastic ECM whose viscosity increases several fold following fertilization (Kim and Kim, 2013). ECM elasticity, or stiffness, has been shown to dramatically affect a variety of cellular processes, such as adhesion of cells to ECM, cell spreading and migration, as well as cell growth, proliferation, and apoptosis (Chaudhuri et al., 2020). A ZP remains around cleavage-stage embryos until the expanded blastocyst stage (≃100–125 cells) when they consist of inner cell mass and trophectoderm and when they hatch from the ZP and implant in the uterus.

Appearance of the ZP during mammalian oogenesis

Commencement of oocyte growth is regulated within the ovary, with the number of growing oocytes dependent on the size of the pool of nongrowing oocytes. Each nongrowing oocyte is surrounded by a few flat mitotic cells that differentiate and multiply profusely during and after oocyte growth and give rise to a very large Graafian follicle from which an unfertilized egg, surrounded by two-to-three layers of cumulus cells, is ovulated in response to hormones (Figure 2). Mouse and human Graafian follicles are ≃600 µm (≃50 thousand cells) and ≃20 mm (≃50 million cells) in diameter, respectively. The cohort of follicle cells, granulosa and thecal cells, that remain behind in the ovary following ovulation become an endocrine gland, the corpus luteum, that supports pregnancy by secreting progesterone.

Drawing of an ovarian Graafian follicle prior to ovulation of an unfertilized egg.

Shown is a fully grown oocyte (pale green) containing a nucleus/germinal vesicle (GV) (red), nucleolus (turquoise), plasma membrane (orange), and zona pellucida (yellow). Two-to-three layers of cumulus cells (brown) surround the oocyte and the innermost cumulus cells, the corona radiata, are indicated by a dashed turquoise circle. The oocyte is connected to the granulosa cells (brown) by a stalk and is located in a fluid filled cavity, the antrum. At the outermost region of the Graafian follicle is a basal lamina (dashed black circle) and outside of this are the theca externa cells (blue). At ovulation, oocytes arrested in metaphase II of meiosis are expelled from the Graafian follicle surrounded by two-to-three layers of cumulus cells. Oocytes resume meiosis, complete the first meiotic reductive division, called meiotic maturation, with separation of homologous chromosomes and emission of the first polar body, and become unfertilized eggs. At fertilization, eggs complete meiosis with separation of chromatids and emission of a second polar body. The sperm’s genome restores the fertilized egg to a diploid state.

Oogenesis begins in the outer layers of ovaries of mouse (≃day 13) and human (≃week 7) fetuses with formation of primordial germ cells that are converted into mitotic oogonia and then into oocytes at various stages of meiotic prophase (Austin, 1972; Conti and Chang, 2016; Larose et al., 2019). Oocytes progress through first meiotic prophase with pairing of homologous chromosomes, crossing-over, and recombination. At birth the ovary is populated with small, nongrowing oocytes that are arrested at the diplotene or dictyate stage of meiosis and lack a ZP. During each reproductive cycle in sexually mature females, oocytes grow, undergo many ultrastructural changes, acquire a thickening ZP (Figure 3), and are the sole source of unfertilized eggs. Mammalian eggs are ≃100 µm in diameter with not much more than a two-to-one variation in size for eggs from different mammals, with the exception of monotremes whose eggs are ≃25 times larger. The width of the ZP for eggs from different mammals varies from ≃2 to ≃22 µm (e.g., mouse ZP, ≃6 µm; human ZP, ≃18 µm).

Graph depicting changes in the width of the mouse oocyte’s zona pellucida during growth of the oocyte.

Mouse oocytes grow from ≃12 µm (nongrowing oocytes) to ≃80 µm in diameter (fully grown oocyte) over 2–3 weeks; this corresponds to more than a 300-fold increase in oocyte volume, from ≃0.9 to ≃300 pl, during oocyte growth. Concomitant with oocyte growth, the zona pellucida increases in width from zero for nongrowing oocytes to ≃6.2 ± 1.9 µm for fully grown oocytes.

Oocyte–follicle cell communication in the ovary

The ovarian follicle is a functional syncytium that provides routes of bidirectional communication between oocytes and follicle cells, with follicle cells regulating oocyte growth and oocytes regulating follicle development (Sugiura and Eppig, 2005; Kidder and Vanderhyden, 2010). Narrow channels, called gap junctions, are present between growing oocytes and neighboring cumulus cells (corona radiata), as well as between all cumulus and granulosa cells (Goodenough and Paul, 2009). Each gap junction channel consists of two protein hexamers, called connexons, that consist of homomeric or heteromeric arrays of connexins, membrane proteins that bridge space between cells (Wei et al., 2004; Hervé, 2018). There are 20 or more different connexins in mice and humans. Gap junctions permit passage of electrical impulses and small molecules less than about 1000 molecular weight (e.g., amino acids, nucleotides, metabolites, ions, and second messengers) between neighboring cells and is regulated by several different proteins that associate with connexins (Alexander and Goldberg, 2003; Giepmans, 2004). Female mice that are homozygous nulls for either connexin-37 (gap junctions between oocytes and granulosa cells) (Simon et al., 1997) or connexin-43 (gap junctions between granulosa cells) (Ackert et al., 2001) fail to ovulate, are deficient in growing oocytes and multilayered follicles, and are completely infertile. This suggests that loss of gap junctions causes disruption of bidirectional communication between oocytes and follicle cells and results in infertility. Related to this is the recent report that interference with formation of oocyte microvilli by deletion of radixin, the microvilli-forming gene, leads to retardation of both oocyte growth and follicle development and to reduced fertility in mice (Zhang et al., 2021).

Mouse and human ZP proteins

The mouse ZP is constructed of three glycosylated proteins, called mZP1–3, that are encoded by single-copy genes located on different chromosomes (Liang and Dean, 1992; Wassarman and Litscher, 2018). mZP2 and mZP3 are monomers and mZP1 is a dimer of identical polypeptides connected by an intermolecular disulfide. The human ZP is constructed of four glycosylated proteins, called hZP1–4, that are also encoded by single-copy genes located on different chromosomes (Gupta, 2018). hZP2 and hZP3 are monomers, hZP1 is a dimer of identical polypeptides connected by an intermolecular disulfide, and hZP4 is either a monomer or dimer held together by noncovalent interactions. Mouse and human ZP protein sequences are ≃63% identical and ≃84% similar and this suggests that the proteins perform identical functions (Chothia et al., 2003). In this context, it has been found that human ZP proteins can substitute for mouse ZP proteins in the mouse ZP (Rankin et al., 2003). In mouse oocytes mZP2 and mZP3 form heterodimers in the extracellular space which then polymerize into long fibrils that exhibit a structural repeat (≃15 nm) (Greve and Wassarman, 1985; Wassarman and Mortillo, 1991). The fibrils are crosslinked by mZP1 and possibly by many noncovalent interactions between fibrils. It can be assumed that ZP fibrils surrounding human oocytes are constructed in a similar manner during oogenesis.

ZP proteins are synthesized as polypeptide precursors by growing oocytes and are processed by proteases prior to secretion into the extracellular space. Nascent mouse and human ZP polypeptides have many features in common (Figure 4). Among these features are: (1) A short signal sequence at the amino- terminus that targets nascent ZP proteins to the secretory pathway and is removed prior to secretion; (2) A ZP domain (ZPD) that consists of two subdomains, ZP-N and ZP-C, separated by a short linker region. The subdomains adopt immunoglobulin-like folds, a three-dimensional structure thought to have arisen ≃750 million years ago in sponges for use in vertebrate extracellular recognition systems (Barclay, 2003). The ZPD is essential for polymerization of extracellular proteins into fibrils and has been found in hundreds of proteins in a wide variety of organisms, from jellyfish to humans (Jovine et al., 2002; Jovine et al., 2005; Plaza et al., 2010; Litscher and Wassarman, 2015); (3) Internal and external hydrophobic patches (IHP and EHP, respectively) that interact with each other in ZP polypeptide precursors and prevent formation of fibrils in oocytes prior to proteolytic processing and secretion; (4) A carboxy-terminal propeptide (CTP) that contains a hydrophobic transmembrane domain used to insert nascent ZP proteins into secretory granule and plasma membrane and a short hydrophilic cytoplasmic tail that is removed by proteolytic cleavage at the consensus furin cleavage site (CFCS) during secretion; (5) mZP1, hZP1, and hZP4 also contain a trefoil domain (TD), possibly involved in crosslinking of ZP fibrils (Järvå et al., 2020), and one extra copy of subdomain ZP-N (N1) near their amino-terminus; mZP2 and hZP2 have three extra copies of ZP-N (N1–3) near their amino-terminus (Callebaut et al., 2007). Processing, secretion, and polymerization of nascent ZP proteins are regulated by polypeptide sequence elements such as the ZP-N, ZP-C, CFCS, CTP, IHP, and EHP (Zhao et al., 2003; Jovine et al., 2004; Jimenez-Movilla and Dean, 2011; Bokhove and Jovine, 2018; Wassarman and Litscher, 2018).

Schematic representation of the organization of mouse zona pellucida proteins, mZP1–3 (623, 713, and 424 amino acids, respectively), and human zona pellucida proteins, hZP1–4 (638, 745, 424, and 540 amino acids, respectively).

In each case, the polypeptide contains a signal sequence (SS) at the N-terminus (pink), a ZP domain (ZPD; black box) consisting of ZP-N (green) and ZP-C (turquoise) subdomains and a short linker region (blue), and a consensus furin cleavage site (CFCS; arrow), transmembrane domain (TMD; yellow), and C-terminal propeptide (CTP). mZP1, hZP1, and hZP4 also have a trefoil domain (brown) adjacent to the ZPD. mZP1, mZP2, hZP1, hZP2, and hZP4 have one or three extra copies of the ZP-N subdomain (green) between the N-terminus of the polypeptides and the ZPD. The positions of the internal (IHP) and external (EHP) hydrophobic patches are indicated by red and orange triangles, respectively. The amino acid numbers for each region of the mouse and human zona pellucida polypeptides are indicated above and below the drawings of the polypeptides.

Inactivation of mouse ZP genes causes infertility

To examine possible effects of the loss of ZP proteins on fertility of mice, mouse lines were established in which genes encoding mZP2 and mZP3 were inactivated by either homologous recombination or insertional mutagenesis (Table 1). Compared to wild-type females, homozygous nulls for genes encoding either mZP2 (mZP2−/−) or mZP3 (mZP3−/−) were completely infertile and exhibited smaller ovaries, reduced numbers of Graafian follicles and ovulated eggs, and fewer cumulus cells that were disorderly arrayed around oocytes (Liu et al., 1996; Rankin et al., 1996; Rankin et al., 2001; Wassarman and Litscher, 2018). These findings suggest that both mZP2 and mZP3 must be present to construct ZP fibrils and that the presence of a ZP around oocytes is essential for fertility in female mice. In this context, homozygous nulls for the gene encoding mZP1 (mZP1−/−) had an abnormal ZP that was insufficiently crosslinked such that cleavage-stage embryos were extremely fragile and often lost as they traversed the female reproductive tract on their way to the uterus (Rankin et al., 1999). Heterozygous nulls for the gene encoding mZP3 (mZP3+/−) were as fertile as wild-type females, but their eggs had a thin ZP (ave. width 2.7 ± 1.2 µm) and contained about one-half the amount of mZP2 and mZP3 found in ZP of eggs from wild-type mice (Wassarman et al., 1997). This suggests that ZP width is not a critical parameter for either binding of sperm to the ZP or fertilization of eggs.

Table 1
Phenotypes of ZP1, 2, 3 null female mice.
GenotypeFertilityZona PellucidaReferences
ZP1–3 wild-typeFertileNormal
ZP1 homozygous-nullReducedAbnormalRankin et al., 1999
ZP2 homozygous-nullInfertileNoneRankin et al., 2001
ZP3 homozygous-nullInfertileNoneRankin et al., 1996;
Liu et al., 1996
ZP3 heterozygous-nullFertileThinWassarman et al., 1997

Mutation of human ZP genes causes infertility

It has been estimated that ≃50% of human infertility cases have a genetic component and that ≃50% are due to a female factor (Deshpande and Gupta, 2019). In 2005, a correlation was found between sequence variations in genes encoding human ZP proteins and fertilization failure (Männikkö et al., 2005). Subsequently, a mutated form of hZP1 was implicated in familial infertility in human females (Huang et al., 2014).

In recent years, more than two dozen cases of infertility in human female patients have been linked to point, missense, or frameshift mutations in human ZP genes encoding hZP1–4 (summarized in Wassarman and Litscher, 2021). Mutations were identified in nine exons encoding hZP1, four exons encoding hZP2, four exons encoding hZP3, and two exons encoding hZP4 (Figure 5). For several of the mutated genes, insertion of a premature stop-codon led to synthesis of truncated forms of human ZP proteins and to the absence of a ZP. More than a dozen of the mutations occurred in exons encoding the ZPD of hZP1–4, in either the ZP-N or ZP-C subdomains or in the linker region, and prevented construction of a ZP around oocytes. Similarly, for hZP1 and hZP4 several mutations occurred in exons encoding the N1 subdomain before the TD and resulted in either the presence of an abnormal ZP or no ZP around oocytes. As expected, the absence of ZP polypeptide sequence elements required for proteolytic processing, secretion, and assembly of nascent ZP proteins during oogenesis resulted in infertility. In every case, infertile patients had either abnormal eggs lacking a ZP or no eggs at all. As with female mice (Table 1), these findings with infertile human patients (Figure 5) suggest that the presence of a ZP around oocytes is essential for fertility in human females.

Schematic representations of mutations in exons encoding human zona pellucida proteins, hZP1–4.

Shown is the organization of exons (red) for hZP1 (12 exons), hZP2 (19 exons), hZP3 (8 exons), and hZP4 (12 exons). Exons subject to mutations that caused infertility are marked by an X. Also shown are schematic representations of hZP1–4 polypeptides with the signal sequence (SS; red), trefoil domain (TD; brown), ZP domain (ZPD) consisting of ZP-N (green) and ZP-C (blue) subdomains, transmembrane domain (TMD; yellow), and extra copies of ZP-N subdomain (green) between the N-terminus of the polypeptides and the ZPD. The sites of mutations in the polypeptides are indicated by black vertical lines.

Conclusions

The findings described here demonstrate that interference with construction of a ZP around growing oocytes, by either inactivation or mutation of genes encoding ZP proteins, results in female infertility in mice and humans. Failure to construct a ZP apparently interferes with bidirectional communication between oocytes and follicle cells in the ovary. Since the ZP is a viscoelastic ECM, it likely provides stability for contacts between projections from innermost cumulus cells (corona radiata) and oocyte microvilli that pass through the ZP and form the gap junctions shown to be essential for oocyte growth and follicle development (Gilula et al., 1978; Li and Albertini, 2013; Clarke, 2018; Baena and Terasaki, 2019). In the absence of a thickening ZP, interactions between growing oocytes and innermost cumulus cells may be unstable, leading to a significant reduction in the number of fully grown oocytes, ovulated eggs, and Graafian follicles and to female infertility. It is likely that further research with infertile women in in vitro fertilization (IVF) clinics will lead to identification of many additional mutations in genes encoding human ZP proteins.

References

  1. Book
    1. Austin CR
    (1972)
    Reproduction in Mammals: 1 Germ Cells and Fertilization
    London, England: Cambridge University Press.
    1. Conti M
    2. Chang RJ
    (2016)
    Folliculogenesis, ovulation, and luteogenesis
    Endocrinology: Adult-Pediatric 2:17.
    1. Goodenough DA
    2. Paul DL
    (2009) Gap junctions
    Cold Spring Harbor Perspectives in Biology 1:a002576.
    https://doi.org/10.1101/cshperspect.a002576
    1. Liang LF
    2. Dean J
    (1992)
    Oocyte development: Molecular biology of the zona pellucida
    Vitamins and Hormones 47:115–159.
    1. Rankin TL
    2. O’Brien M
    3. Lee E
    4. Wigglesworth K
    5. Eppig J
    6. Dean J
    (2001)
    Defective zonae pellucidae in Zp2-null mice disrupt folliculogenesis, fertility and development
    Development 128:1119–1126.

Article and author information

Author details

  1. Paul M Wassarman

    Department Cell, Developmental, and Regenerative Biology Icahn School of Medicine at Mount Sinai One Gustave L. Levy Place, New York, United States
    Contribution
    Conceptualization
    For correspondence
    paul.wassarman@mssm.edu
    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-0924-4039
  2. Eveline S Litscher

    Department Cell, Developmental, and Regenerative Biology Icahn School of Medicine at Mount Sinai One Gustave L. Levy Place, New York, United States
    Contribution
    Conceptualization
    Competing interests
    No competing interests declared

Funding

No external funding was received for this work.

Acknowledgements

We are grateful to all members of our laboratory who contributed to our research on the zona pellucida at Harvard Medical School, Roche Institute of Molecular Biology, and Icahn School of Medicine at Mount Sinai. Our research was supported in part by the National Institutes of Health (NICHD, HD-35105) and F Hoffmann-La Roche AG.

Senior and Reviewing Editor

  1. Mone Zaidi, Icahn School of Medicine at Mount Sinai, United States

Publication history

  1. Received: December 6, 2021
  2. Accepted: January 7, 2022
  3. Version of Record published: January 25, 2022 (version 1)
  4. Version of Record updated: February 22, 2022 (version 2)

Copyright

© 2022, Wassarman and Litscher

This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,569
    Page views
  • 153
    Downloads
  • 1
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Paul M Wassarman
  2. Eveline S Litscher
(2022)
Female fertility and the zona pellucida
eLife 11:e76106.
https://doi.org/10.7554/eLife.76106

Further reading

    1. Cell Biology
    2. Genetics and Genomics
    Peter S Johnstone, Maite Ogueta ... Deniz Top
    Tools and Resources

    Circadian clocks are highly conserved transcriptional regulators that control ~24-hour oscillations in gene expression, physiological function, and behavior. Circadian clocks exist in almost every tissue and are thought to control tissue-specific gene expression and function, synchronized by the brain clock. Many disease states are associated with loss of circadian regulation. How and when circadian clocks fail during pathogenesis remains largely unknown because it is currently difficult to monitor tissue-specific clock function in intact organisms. Here, we developed a method to directly measure the transcriptional oscillation of distinct neuronal and peripheral clocks in live, intact Drosophila, which we term Locally Activatable BioLuminescence, or LABL. Using this method, we observed that specific neuronal and peripheral clocks exhibit distinct transcriptional properties. Loss of the receptor for PDF, a circadian neurotransmitter critical for the function of the brain clock, disrupts circadian locomotor activity but not all tissue-specific circadian clocks. We found that, while peripheral clocks in non-neuronal tissues were less stable after the loss of PDF signaling, they continued to oscillate. We also demonstrate that distinct clocks exhibit differences in their loss of oscillatory amplitude or their change in period, depending on their anatomical location, mutation, or fly age. Our results demonstrate that LABL is an effective tool that allows rapid, affordable, and direct real-time monitoring of individual clocks in vivo.

    1. Biochemistry and Chemical Biology
    2. Cell Biology
    Dirk H Siepe, Lukas T Henneberg ... K Christopher Garcia
    Tools and Resources

    Secreted proteins, which include cytokines, hormones and growth factors, are extracellular ligands that control key signaling pathways mediating cell-cell communication within and between tissues and organs. Many drugs target secreted ligands and their cell-surface receptors. Still, there are hundreds of secreted human proteins that either have no identified receptors ('orphans') and are likely to act through cell surface receptors that have not yet been characterized. Discovery of secreted ligand-receptor interactions by high-throughput screening has been problematic, because the most commonly used high-throughput methods for protein-protein interaction (PPI) screening do not work well for extracellular interactions. Cell-based screening is a promising technology for definition of new ligand-receptor interactions, because multimerized ligands can enrich for cells expressing low affinity cell-surface receptors, and such methods do not require purification of receptor extracellular domains. Here, we present a proteo-genomic cell-based CRISPR activation (CRISPRa) enrichment screening platform employing customized pooled cell surface receptor sgRNA libraries in combination with a magnetic bead selection-based enrichment workflow for rapid, parallel ligand-receptor deorphanization. We curated 80 potentially high value orphan secreted proteins and ultimately screened 20 secreted ligands against two cell sgRNA libraries with targeted expression of all single-pass (TM1) or multi-pass (TM2+) receptors by CRISPRa. We identified previously unknown interactions in 12 of these screens, and validated several of them using surface plasmon resonance and/or cell binding. The newly deorphanized ligands include three receptor tyrosine phosphatase (RPTP) ligands and a chemokine like protein that binds to killer cell inhibitory receptors (KIR's). These new interactions provide a resource for future investigations of interactions between the human secreted and membrane proteomes.